• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.01%

    Orexigen Therapeutics, Inc. (OREX)

    -NasdaqGS
    4.00 Up 0.05(1.27%) Jul 31, 4:00PM EDT
    |After Hours : 4.00 0.00 (0.00%) Jul 31, 5:37PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2015Dec 31, 2014Sep 30, 2014Jun 30, 2014
    Total Revenue 4,359   22,950   30,857   857  
    Cost of Revenue -   -   -   -  
    Gross Profit 4,359   22,950   30,857   857  
    Operating Expenses
    Research Development11,242  12,966  10,719  16,726  
    Selling General and Administrative8,584  7,599  7,097  6,933  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (15,467) 2,385   13,041   (22,802)
    Income from Continuing Operations
    Total Other Income/Expenses Net63  20  16  26  
    Earnings Before Interest And Taxes(15,404)2,405  13,057  (22,776)
    Interest Expense1,829  1,798  1,784  1,731  
    Income Before Tax(17,233)607  11,273  (24,507)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(17,233)607  11,273  (24,507)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (17,233) 607   11,273   (24,507)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (17,233) 607   11,273   (24,507)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.